A technology-intensive science and technology enterprise, dedicated to the R&D of new biotechnology products. Business Approach: The company takes precise market segmentation as the starting point of its business. R&D Focus: The research and development mainly focuses on recombinant antigens for in vitro diagnosis (IVD) of human infectious diseases and new technologies for diagnostic kits. Enterprise Status: It is a national high-tech enterprise, a high-tech enterprise in Zhongguancun, and an innovative small and medium-sized enterprise in Beijing. Current Mature Products: Currently, the mature products include recombinant antigens such as HBsAg, HBcAg, HBeAg, TP, HEV, and MP. Company Strategy: Focus on creating high-quality products to serve customers. Company Mission: Through in-depth research on the nature of raw materials and their applications, assist users in producing IVD kits more smoothly and reliably with better performance, providing people with more accurate detection results help employees achieve their goals, enhance their self-worth, and obtain substantial income to a happy life. Company Vision: the best-quality recombinant antigens in the industry through extreme innovation and become the absolute industry benchmark for recombinant antigens used in IVD.
If you are interested in booking a stand at CACLP, please leave your details below and one of our representatives will be in touch soon.
Copyright © 2026 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )
We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News.
sign-up for our newsletter today.
To ensure our newsletter hit your inbox, make sure to add @caclp.com to your safe senders list. And, as always, feel free to contact
us with any questions and thanks again for subscribing.